Rethinking osteoporosis: balancing risk and benefit in diagnosis, prevention, and treatment.
The standard of care for osteoporosis is changing amid questions about the long-term safety and efficacy of curren drugs for preventing and treating osteoporosis. This article provides a guide for evidence-based treatment, but not over-treatment, as well as the selection and duration of available drug therapies.
Wake Forest School of Medicine, Winston-Salem, North Carolina, USA.
Alice
A
Smith
Brittany
B
Shaw
Danielle
D
Laliberte
Jennifer
J
Langston
Reamer L
RL
Bushardt
D050071:Bone Density Conservation Agents / Q000627:therapeutic use; D006801:Humans; D008019:Life Style; D010024:Osteoporosis / Q000175:diagnosis* / Q000209:etiology / Q000628:therapy*; D058866:Osteoporotic Fractures / Q000209:etiology / Q000517:prevention & control*; D012307:Risk Factors; D040242:Risk Reduction Behavior
D050071:Bone Density Conservation Agents